On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
The potential benefits and harms associated with available treatments for ADHD in adults are unclear, especially when considering different types of interventions. We conducted a systematic review and a series of component network meta-analyses of 113 studies with 14,887 participants to jointly evaluate the performance of medications, psychological treatments, and neurostimulation at 12, 26, and 52 weeks. We evaluated these treatments against a common comparator (pill placebo) in terms of how well they reduced ADHD symptoms according to self-reports and clinician ratings, their acceptability (any-cause discontinuation), tolerability (discontinuation due to adverse events), and their effect on emotional dysregulation, executive dysfunctions, and quality of life.
This seminar is hosted in person and online, to join online, please use the Zoom details below:
zoom.us/j/93598736019?pwd=tHJ65nmXIrmYTUhi7YRbbdlnyi5Ie6.1
Meeting ID: 935 9873 6019
Passcode: 897963
